718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models

718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models

Bibliographic Details
Main Authors:	Christopher Nirschl, Kristin Morris, Heather Brodkin, Daniel Hicklin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

1059 Spatial analysis of tumor infiltrating lymphocyte populations in syngeneic mouse tumor models after treatment with IL-12 (mWTX-330) and IL-2 (WTX-124) INDUKINETM molecules
by: Christopher J Nirschl, et al.
Published: (2023-11-01)

723 WTX-613, a conditionally activated IFNα INDUKINE™ molecule, induces anti-tumor immune responses resulting in strong tumor growth control in syngeneic mouse tumor models
by: Christopher Nirschl, et al.
Published: (2021-11-01)

1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment
by: Christopher J Nirschl, et al.
Published: (2023-11-01)

1075 Development of WTX-712, a conditionally active IL-21 INDUKINETM molecule for the treatment of cancer
by: Kyriakos Economides, et al.
Published: (2023-11-01)

1074 PK/RO modeling of WTX-124, a tumor-activated IL-2 prodrug, highlights the potential for a substantially improved therapeutic index compared to other IL-2 molecules
by: Christopher J Nirschl, et al.
Published: (2023-11-01)

252 The combination of ACT and INDUKINE therapy leads to improved antitumor immunity in solid tumors
by: Kyriakos Economides, et al.
Published: (2023-11-01)

WTX beyond WNT signaling pathway
by: Zhang Qingling, et al.
Published: (2023-01-01)

737 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in patients with immunotherapy-sensitive locally advanced or metastatic solid tumors
by: Brendan Curti, et al.
Published: (2023-11-01)

The <it>WTX/AMER1 </it>gene family: evolution, signature and function
by: Boutet Agnès, et al.
Published: (2010-09-01)

Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models
by: Apeng Chen, et al.
Published: (2023-03-01)

Variants in the AMER1/WTX gene as a possible cause of idiopathic osteoporosis
by: Caroline Caetano, et al.
Published: (2021-04-01)

A benzimidazole derivative as an effective antitumor agent in terms of syngeneic lung tumors and melanoma treatment
by: E. F. Komarova, et al.
Published: (2022-03-01)

Antitumor Activity of Kielmeyera Coriacea Leaf Constituents in Experimental Melanoma, Tested in Vitro and in Vivo in Syngeneic Mice
by: Carlos Rogério Figueiredo, et al.
Published: (2014-10-01)

Mutations in the <it>WTX </it>- gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers
by: Scheel Silvio K, et al.
Published: (2010-08-01)

IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models
by: Hongtai Shi, et al.
Published: (2023-07-01)

Abstract OR-3: Integrative Structural Study of the Complex of Snake Toxin WTX with α7-type Nicotinic Acetylcholine Receptor
by: Ekaterina N. Lyukmanova, et al.
Published: (2021-06-01)

MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.
by: Tong Li, et al.
Published: (2019-01-01)

261 Synergistic antitumor effects of mouse mesothelin-directed CAR (mmeso-CAR) T cells and αCD40 in a syngeneic model of PDAC
by: Carl H June, et al.
Published: (2023-11-01)

Mutational spectrum of <it>WTX</it>, <it>WT1</it>, <it>CTNNB1</it>, <it>APC</it> and <it>PLCG2</it> genes in Wilms tumor defined by massive parallel resequencing
by: Barros Bruna D, et al.
Published: (2012-10-01)

Correction: MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.
by: Tong Li, et al.
Published: (2019-01-01)

Syngeneic leukemia models using lentiviral transgenics
by: Nurit Keinan, et al.
Published: (2021-02-01)

Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice
by: Marcin Komorowski, et al.
Published: (2018-08-01)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
by: Jenna N. Regan, et al.
Published: (2017-12-01)

Retraction Note: Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression
by: Gui-fang Zhu, et al.
Published: (2023-09-01)

RETRACTED ARTICLE: Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression
by: Gui-fang Zhu, et al.
Published: (2019-01-01)

Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells
by: Michael Chamo, et al.
Published: (2023-01-01)

Immunization with HIV protease peptides linked to syngeneic erythrocytes
by: Hallermalm Kristian, et al.
Published: (2007-04-01)

Preparation and antitumor effects of 4-amino-1,2,4-triazole Schiff base derivative
by: Guo-wei Jiang, et al.
Published: (2020-02-01)

Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model.
by: Takayuki Yoshino, et al.
Published: (2019-01-01)

Effect of Inclusions on the Corrosion Properties of the Nickel-Based Alloys 718 and EP718
by: Ekaterina Alekseeva, et al.
Published: (2020-09-01)

Fatigue and fracture in Inconel 718-copper-Inconel 718 explosion-bonded composites
by: Chen, Qiguang.
Published: (2020)

Characterization of immune cell populations in syngeneic murine tumor models
by: Sofie Snipstad, et al.
Published: (2023-05-01)

Development of a syngeneic mouse model of epithelial ovarian cancer
by: Quinn Bridget A, et al.
Published: (2010-10-01)

Membrane Antigen Expression of Syngeneically but Heterotopically Transplanted Hepatocytes in Rats
by: Y. Fujikura, et al.
Published: (1994-01-01)

Reversal of Experimental Diabetes by Injection of Syngeneic Islets into Peripheral Veins
by: Alberto Hayek, et al.
Published: (1992-01-01)

Decidual-Placental Immune Landscape During Syngeneic Murine Pregnancy
by: Yan Li, et al.
Published: (2018-09-01)

Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft
by: Pengfei Chen, et al.
Published: (2022-06-01)

Characterization of Long-Term Survival of Syngeneic Hepatocytes in Rat Peritoneum
by: Clare Selden DR., et al.
Published: (2003-09-01)

Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway
by: Jian Li, et al.
Published: (2021-01-01)

1402 A potent, CD8 T cell targeted IL-2 A-Kine with a broad therapeutic window induces antitumor immunity in syngeneic and humanized mouse tumor models
by: Jared E Lopes, et al.
Published: (2023-11-01)